John Erb is chair and chief executive of CHF Solutions, a manufacturer of medical devices for the heart failure market.
Mr Erb was previously chair of Vascular Solutions, a manufacturer of medical devices for the cardiology and interventional radiology markets, which was acquired in 2017 by Teleflex for US$1 billion. He has held numerous board positions including at CryoCath Technologies and SenoRx which we both subsequently acquired for US$350 million and US$250 million respectively.